Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:41 AM
Ignite Modification Date:
2025-12-25 @ 1:41 AM
NCT ID:
NCT06102694
Eligibility Criteria:
Inclusion Criteria:
* 1\. Diagnosis of a hematologic disease (e.g., leukemia, myelodysplastic syndromes,lymphoma) confirmed by histology or other appropriate diagnostic methods.
* 2\. undergoing allo-HSCT
* 3\. Age 14 years or older
* 4.Informed consent must be signed before the start of the study. For participants aged 18 and above, the informed consent should be signed by the patient or their immediate family member. Considering the patient's condition, if it is not favorable for the patient to sign, the informed consent may be signed by a legal guardian or immediate family member of the patient.
Exclusion Criteria:
* 1\. Missing or lost follow-up of key clinical data
* 2\. failure to collect plasma samples at specific time points after transplantation
* 3\. Plasma sample collection time later than the onset date of TMA
* 4\. TMA occurrence time later than 180 days after transplantation
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
14 Years
Maximum Age:
70 Years
Study:
NCT06102694
Study Brief:
Protocol Section:
NCT06102694